Showing results (2251-2260 of 3,596) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|September 11, 2004
Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infectionsC Hézode, F Roudot-Thoraval, E-S Zafrani, et al.Journal of Viral Hepatitis|October 27, 2004
Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5J Nattermann, H D Nischalke, G Feldmann, et al.Journal of Viral Hepatitis|October 27, 2004
Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational databaseN Voirin, C Trépo, P Miailhes, et al.Journal of Viral Hepatitis|July 3, 2004
Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic optionsG V Papatheodoridis, E CholongitasJournal of Viral Hepatitis|July 3, 2004
Lymphoproliferative disorders in chronic hepatitis CR Idilman, A Colantoni, N De Maria, et al.Journal of Viral Hepatitis|July 3, 2004
Analysis of CCR5-Delta 32 and CCR2-V64I polymorphisms in a cohort of Spanish HCV patients using real-time polymerase chain reaction and fluorescence resonance energy transfer technologiesM Ruiz-Ferrer, N Barroso, G Antiñolo, et al.Journal of Viral Hepatitis|January 24, 2004
Detection and quantitation of HCV core protein in single hepatocytes by means of laser capture microdissection and enzyme-linked immunosorbent assayD Sansonno, G Lauletta, F DammaccoJournal of Viral Hepatitis|January 24, 2004
Effect of interferon alpha and cell cycle progression on translation mediated by the hepatitis C virus 5' untranslated region: a study using a transgenic mouse modelY Takeda, S Okoshi, K Suzuki, et al.Journal of Viral Hepatitis|January 24, 2004
High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapyS Zhong, W Yeo, C Schroder, et al.Journal of Viral Hepatitis|January 24, 2004
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trialP Andreone, A Gramenzi, C Cursaro, et al.Pageof 360